Treatment of vaccinial keratitis with vidarabine
R. A. Hyndiuk, M. Okumoto, R. A. Damiano, M. Valenton and G. Smolin
Vaccinial epithelial keratitis was produced in rabbits. When the
therapeutic effect of vidarabine on the experimentally-induced disease was
evaluated and compared to the effect of idoxuridine, vidarabine was found
to be highly effective, substantially more effective than idoxuridine, and
nontoxic to the eye.
